Drug
PF-07976016 clinical trials
Also written PF-07976016.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2024
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2024 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses PF-07976016 is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study to Learn About the Study Medicine Called PF-07976016 in Adults With ObesityCompletedPhase 2PfizerNCT06717425Written as PF-07976016
- A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy AdultsCompletedPhase 1PfizerNCT06670170Written as PF-07976016 Formulation A
- A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy MenCompletedPhase 1PfizerNCT07015918Written as PF-07976016
- Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or ObesityTerminatedPhase 1PfizerNCT06910839Written as PF-07976016